Colgate-Palmolive

B of A Securities analyst Bryan Spillane maintains Colgate-Palmolive (NYSE:CL) with a Neutral and lowers the price target from $85 to $75.

Colgate-Palmolive (NYSE:CL) reported Q2 adjusted earnings Friday of $0.77 per diluted share, up from $0.72 a year earlier. Analysts polled by Capital IQ expected adjusted EPS of $0.75. Net sales for the quarter ended June 30 were $4.82 billion, compared with $4.48 billion a year earlier. Analysts surveyed by Capital IQ estimated $4.70 billion. Colgate-Palmolive said it now expects full-year EPS growth to be at the high end of mid-single-digits, compared with the previous forecast of a mid-single-digit growth, and a 5% to 8% increase in net sales compared with the initial estimate of a 3% to 6% increase. Analysts polled by Capital IQ estimate an adjusted EPS of $3.15 on revenue of $19.15 billion.